Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder

In a prior study, topiramate reduced heavy drinking among individuals who sought to reduce their drinking, with the effect moderated by a single nucleotide polymorphism (SNP; rs2832407) in GRIK1, which encodes the kainate GluK1 receptor subunit (Kranzler et al. 2014). The present study sought to rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kranzler, Henry R., Morris, Paige E., Pond, Timothy, Crist, Richard C., Kampman, Kyle M., Hartwell, Emily E., Lynch, Kevin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209023/
https://www.ncbi.nlm.nih.gov/pubmed/33568796
http://dx.doi.org/10.1038/s41386-020-00945-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209023/
https://www.ncbi.nlm.nih.gov/pubmed/33568796
http://dx.doi.org/10.1038/s41386-020-00945-9

Ejemplares similares